Total amount raised
$57.2 Million
Latest funding date
05/01/2022
Location
Osmind has successfully raised funding over four rounds, with the latest being a Series B round led by DFJ Growth. The company is backed by a total of 21 investors, including recent ones like Helena Goodman and AME Cloud Ventures.
Keep reading to explore the intricacies of Osmind's fundraising journey and the investors backing this innovative platform.
What Is Osmind?
Osmind is a premier technology platform focused on breakthrough mental health treatment and research. Based in San Francisco, California, the company operates in the health care, medical, and mental health industries. Osmind provides a comprehensive suite of services for psychiatry practices, including a specialized electronic health record (EHR) system and billing services.
Founded with the mission to advance mental health care, Osmind has grown to employ between 51 and 100 people. The company is currently in the Series B funding stage and is supported by 21 investors. Osmind aims to help psychiatric clinicians increase profitability, reduce administrative burdens, and stay updated with the latest advancements in mental health care.
How Much Funding Has Osmind Raised?
- Pre-seed Funding Round
- Amount Raised: USD 175,000
- Date: August 2020
- Lead Investors: Y Combinator
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To kickstart the development of Osmind's platform and establish initial operations.
- Seed Funding Round
- Amount Raised: USD 2,000,000
- Date: October 2020
- Lead Investors: General Catalyst
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand Osmind's electronic health record (EHR) software and analytics platform.
- Series A Funding Round
- Amount Raised: USD 15,000,000
- Date: July 2021
- Lead Investors: Future Ventures
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To scale the platform and enhance its capabilities for mental health providers.
- Series B Funding Round
- Amount Raised: USD 40,000,000
- Date: May 2022
- Lead Investors: DFJ Growth
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To further develop and expand Osmind's services and reach more psychiatric practices.
Total Amount Raised: USD 57,175,000. Current Valuation: Not publicly disclosed.
Key Investors
- DFJ Growth
- Details: DFJ Growth is a venture capital firm that invests in high-growth technology companies. They led the Series B funding round for Osmind.
- Investment Focus Areas: Technology, healthcare, and energy.
- Notable Investments: SpaceX, Tesla, SolarCity.
- Future Ventures
- Details: Future Ventures is a venture capital firm that focuses on funding visionary entrepreneurs. They led the Series A funding round for Osmind.
- Investment Focus Areas: Biotechnology, space exploration, and artificial intelligence.
- Notable Investments: SpaceX, Neuralink, Planet Labs.
- General Catalyst
- Details: General Catalyst is a venture capital firm that invests in early-stage and growth-stage companies. They led the Seed funding round for Osmind.
- Investment Focus Areas: Healthcare, technology, and consumer sectors.
- Notable Investments: Mindstrong, Sondermind, Airbnb.
- Y Combinator
- Details: Y Combinator is a startup accelerator that provides seed funding and support to early-stage companies. They were a lead investor in the Pre-seed funding round for Osmind.
- Investment Focus Areas: Technology, healthcare, and consumer products.
- Notable Investments: Dropbox, Airbnb, Stripe.
- Pear VC
- Details: Pear VC is a venture capital firm that invests in early-stage startups. They have been involved in multiple funding rounds for Osmind.
- Investment Focus Areas: Early-stage technology and healthcare startups.
- Notable Investments: DoorDash, Guardant Health, Gusto.
What's Next for Osmind?
Osmind stands at the cusp of significant growth, driven by the expansion of its electronic health record software and analytics platform. With a focus on treatment-resistant mental health conditions, the company aims to improve patient engagement and enable remote monitoring, addressing a critical need in the mental health industry. The potential to serve more than the current 20,000 patients across 125 practices highlights the vast opportunity ahead.
Future fundraising rounds are likely as Osmind continues to demonstrate success and scalability. The growing interest in innovative treatments like psychedelic medicine and neuromodulation positions the company well for attracting additional investors. However, challenges such as integrating seamlessly into existing clinical workflows and navigating regulatory issues will need to be addressed to ensure sustained growth and efficacy.
Use Clay to Get Funding Data
Sales professionals, leverage Clay’s platform to access comprehensive fundraising data on companies like Osmind and gather other critical business insights. Sign up for free to start transforming your sales strategy today.
